FDA
approval
· 2013-04-19
FDA Approved: EDLUAR — Supplemental Application (Viatris Specialty LLC)
Summary
The FDA approved Viatris Specialty LLC's supplemental application for EDLUAR (zolpidem tartrate), a brand product used to treat insomnia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EDLUAR (ZOLPIDEM TARTRATE)